World Economic Forum December 5, 2019
- Venture capital can turn scientific discoveries into products for patients in low and middle income countries.
- It has transformed the market for rare disease medicines, bringing huge benefit to patients worldwide.
- Healthcare innovation in low-income countries driven by a venture capital model could also benefit high-income countries, which share the same disease challenges.
Important gains have been made in global health in the past few decades: the rate of deaths caused by malaria has halved, HIV/AIDS is no longer a death sentence and the same might soon be true for Ebola judging by the...